Evommune, Inc. (EVMN) Net margin 2024–2025
Evommune, Inc. (EVMN) net profit margin by fiscal year — reported net income divided by reported revenue.
-529.8%FY2025 · since FY2024: -954.4% → -529.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -529.8% | +424.6 pp |
| FY2024 | -954.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice